Note 1 - Organization of the Company

9 Months Ended

Sep. 30, 2020

Notes to Financial Statements

Nature of Operations [Text Block]

Organization of the Company

We are a specialist biosensors company focused on the development, manufacture and commercialization of a range of point-of-use devices for measuring different analytes across different industries. In addition, we own, manage and operate a hemostasis laboratory.

Key aspects of our strategy for increasing shareholder value include:

● executing on our business activities, including commercializing our existing product portfolio, undertaking research and development activities, manufacturing products and providing development and support services including providing laboratory services;

● extending and demonstrating the broader application of our technology and seeking to enter into collaborative, strategic or distribution arrangements with industry participants with respect to specific tests or specific fields; and

● identifying and pursuing related opportunities for growth.

Our plan of operations over the remainder of the fiscal year ending

December 2020

is to:

● finalise the development of our Free Sulphur wine testing product;

● seek to enter into collaborative, strategic or distribution arrangements with industry participants with respect to the development and commercialization of our products;

● manufacture products;

● undertake research and development work;

● provide the necessary post-market support for our customers and partners;

● provide laboratory services for our customers and partners;

● develop new applications for our technology platform in markets with significant commercial potential; and

● identify, investigate and evaluate merger & acquisition opportunities.